YEAR 2009-SINOVAC: Supply Vaccines to Eliminate Human Diseases-page5

Company
Innovation
Products

News
Investors
Careers
- Our Talent
中文 EN
Contact Us

Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

联系我们

当前地点：

EN

选择地点：

中文
EN

Home
Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

中文
EN

SEC Filings

ALL YEAR

ALL YEAR
YEAR 2025
YEAR 2024
YEAR 2023
YEAR 2022
YEAR 2021
YEAR 2020
YEAR 2019
YEAR 2018
YEAR 2017
YEAR 2016
YEAR 2015
YEAR 2014
YEAR 2013
YEAR 2012
YEAR 2011
YEAR 2010
YEAR 2009

Filings：20-F/A

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Acc-no: 0001193125-09-178612 (34 Act)

2009/08/20
Filings：SC 13G/A

Statement of acquisition of beneficial ownership by individuals

Acc-no: 0001193125-09-147035 (34 Act)

2009/07/10
Filings：6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

Acc-no: 0001127855-09-000189 (34 Act)

2009/05/06
Filings：6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

Acc-no: 0001127855-09-000187 (34 Act)

2009/05/06
Filings：6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

Acc-no: 0001127855-09-000185 (34 Act)

2009/05/06
Filings：6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

Acc-no: 0001127855-09-000183 (34 Act)

2009/05/06
Filings：6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

Acc-no: 0001127855-09-000181 (34 Act)

2009/05/06
Report of foreign issuer [Rules 13a-16 and 15d-16]

Acc-no: 0001127855-09-000179 (34 Act)

2009/05/06

Previous page 1 2 3 4 5 6 Next page Go to No.

Follow Us

© SINOVAC All rights reserved